» Articles » PMID: 35255645

Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Viruses are a significant cause of morbidity and mortality around the world. Determining the minimum dose of virus particles that can initiate infection, termed the minimum infective dose (MID), is important for the development of risk assessment models in the fields of food and water treatment and the implementation of appropriate infection control strategies in healthcare settings. Both respiratory and enteric viruses can be shed at high titers from infected individuals even when the infection is asymptomatic. Presence of pre-existing antibodies has been shown to affect the infectious dose and to be protective against reinfection for many, but not all viruses. Most respiratory viruses appear to be as infective in humans as in tissue culture. Doses of <1 TCID of influenza virus, rhinovirus, and adenovirus were reported to infect 50% of the tested population. Similarly, low doses of the enteric viruses, norovirus, rotavirus, echovirus, poliovirus, and hepatitis A virus, caused infection in at least some of the volunteers tested. A number of factors may influence viruses' infectivity in experimentally infected human volunteers. These include host and pathogen factors as well as the experimental methodology. As a result, the reported infective doses of human viruses have to be interpreted with caution.

Citing Articles

Rapid virucidal activity of an air sanitizer against aerosolized MS2 and Phi6 phage surrogates for non-enveloped and enveloped vertebrate viruses, including SARS-CoV-2.

Ijaz M, Zargar B, Nims R, McKinney J, Sattar S Appl Environ Microbiol. 2024; 91(1):e0142624.

PMID: 39641606 PMC: 11784435. DOI: 10.1128/aem.01426-24.


A vaccine platform targeting lung-resident memory CD4 T-cells provides protection against heterosubtypic influenza infections in mice and ferrets.

Ko K, Bae H, Park J, Lee J, Park S, Heo J Nat Commun. 2024; 15(1):10368.

PMID: 39609429 PMC: 11604757. DOI: 10.1038/s41467-024-54620-4.


Avian influenza subtype H5N1 in US dairy-A preliminary dairy foods perspective.

Martin N, Trmcic A, Alcaine S JDS Commun. 2024; 5(Suppl 1):S4-S7.

PMID: 39429894 PMC: 11489421. DOI: 10.3168/jdsc.2024-0634.


Chemical inactivation of two non-enveloped viruses results in distinct thermal unfolding patterns and morphological alterations.

Narula P, Lokshman M, Pathak S, Mukherjee S, Banerjee M BMC Microbiol. 2024; 24(1):413.

PMID: 39420248 PMC: 11484109. DOI: 10.1186/s12866-024-03565-1.


Invasions of Host-Associated Microbiome Networks.

Murall C, Abbate J, Touzel M, Allen-Vercoe E, Alizon S, Froissart R Adv Ecol Res. 2024; 57:201-281.

PMID: 39404686 PMC: 7616576. DOI: 10.1016/bs.aecr.2016.11.002.


References
1.
Bell J, HUEBNER R, Paffenbarger Jr R, Rowe W, SUSKIND R, WARD T . Studies of adenoviruses (APC) in volunteers. Am J Public Health Nations Health. 1956; 46(9):1130-46. PMC: 1624049. DOI: 10.2105/ajph.46.9.1130. View

2.
Westblom T, Gudipati S, DeRousse C, Midkiff B, Belshe R . Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule. J Infect Dis. 1994; 169(5):996-1001. DOI: 10.1093/infdis/169.5.996. View

3.
Clements M, SNYDER M, Sears S, Maassab H, Murphy B . Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. J Infect Dis. 1990; 161(5):869-77. DOI: 10.1093/infdis/161.5.869. View

4.
Tellier R . Review of aerosol transmission of influenza A virus. Emerg Infect Dis. 2007; 12(11):1657-62. PMC: 3372341. DOI: 10.3201/eid1211.060426. View

5.
Hayden F, Tunkel A, Treanor J, Betts R, Allerheiligen S, Harris J . Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans. Antimicrob Agents Chemother. 1994; 38(5):1178-81. PMC: 188174. DOI: 10.1128/AAC.38.5.1178. View